William E. Hobbs

1.7k total citations
29 papers, 895 citations indexed

About

William E. Hobbs is a scholar working on Hematology, Genetics and Molecular Biology. According to data from OpenAlex, William E. Hobbs has authored 29 papers receiving a total of 895 indexed citations (citations by other indexed papers that have themselves been cited), including 14 papers in Hematology, 12 papers in Genetics and 7 papers in Molecular Biology. Recurrent topics in William E. Hobbs's work include Blood groups and transfusion (10 papers), Hemoglobinopathies and Related Disorders (8 papers) and Chronic Lymphocytic Leukemia Research (4 papers). William E. Hobbs is often cited by papers focused on Blood groups and transfusion (10 papers), Hemoglobinopathies and Related Disorders (8 papers) and Chronic Lymphocytic Leukemia Research (4 papers). William E. Hobbs collaborates with scholars based in United States, Germany and United Kingdom. William E. Hobbs's co-authors include Neal A. DeLuca, Paul E. Carlson, Brian J. Manning, K. Grant Taylor, David J. Kuter, Alexander Röth, Catherine M. Broome, Caroline Reuter, Jennie Le and Junmei Chen and has published in prestigious journals such as New England Journal of Medicine, Blood and Journal of Virology.

In The Last Decade

William E. Hobbs

28 papers receiving 865 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
William E. Hobbs United States 14 319 282 274 182 163 29 895
Jennifer Barks United States 10 141 0.4× 304 1.1× 124 0.5× 192 1.1× 68 0.4× 10 952
Kurt C. Sizer United States 15 316 1.0× 134 0.5× 220 0.8× 214 1.2× 83 0.5× 20 1.1k
Lacramioara Ivanciu United States 17 150 0.5× 324 1.1× 497 1.8× 456 2.5× 128 0.8× 31 1.3k
Timothy A. Driscoll United States 15 193 0.6× 213 0.8× 411 1.5× 257 1.4× 81 0.5× 35 976
Carsten Berges Germany 15 148 0.5× 304 1.1× 274 1.0× 351 1.9× 75 0.5× 25 926
Y. Matsuda Japan 19 211 0.7× 165 0.6× 129 0.5× 329 1.8× 71 0.4× 38 989
Cristian R. Smulski Argentina 16 127 0.4× 500 1.8× 65 0.2× 251 1.4× 69 0.4× 33 926
Laphalle Fuller United States 19 125 0.4× 436 1.5× 264 1.0× 208 1.1× 110 0.7× 81 1.2k
Michael Plotnick United States 14 67 0.2× 204 0.7× 114 0.4× 234 1.3× 122 0.7× 15 715
Drago Batinić Croatia 16 56 0.2× 188 0.7× 258 0.9× 352 1.9× 47 0.3× 78 875

Countries citing papers authored by William E. Hobbs

Since Specialization
Citations

This map shows the geographic impact of William E. Hobbs's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by William E. Hobbs with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites William E. Hobbs more than expected).

Fields of papers citing papers by William E. Hobbs

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by William E. Hobbs. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by William E. Hobbs. The network helps show where William E. Hobbs may publish in the future.

Co-authorship network of co-authors of William E. Hobbs

This figure shows the co-authorship network connecting the top 25 collaborators of William E. Hobbs. A scholar is included among the top collaborators of William E. Hobbs based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with William E. Hobbs. William E. Hobbs is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Röth, Alexander, Wilma Barcellini, Tor Henrik Anderson Tvedt, et al.. (2022). Sutimlimab improves quality of life in patients with cold agglutinin disease: results of patient-reported outcomes from the CARDINAL study. Annals of Hematology. 101(10). 2169–2177. 13 indexed citations
2.
Röth, Alexander, Wilma Barcellini, Shirley D’Sa, et al.. (2021). Sutimlimab in Cold Agglutinin Disease. New England Journal of Medicine. 384(14). 1323–1334. 127 indexed citations
3.
Broome, Catherine M., Alexander Röth, David J. Kuter, et al.. (2020). Long-Term Safety and Efficacy of Sutimlimab in Patients with Chronic Immune Thrombocytopenia. Blood. 136(Supplement 1). 14–15. 12 indexed citations
4.
Krishnamoorthy, Sriram, Betty S. Pace, Dipti Gupta, et al.. (2017). Dimethyl fumarate increases fetal hemoglobin, provides heme detoxification, and corrects anemia in sickle cell disease. JCI Insight. 2(20). 36 indexed citations
5.
Currier, Nicolas, Gersham Dent, Paul Swerdlow, et al.. (2016). Skin Blood Flow Measured By LSCI Demonstrates Treatment Effect of Chronic Transfusion Protocol in Sickle Cell Disease. Blood. 128(22). 4871–4871. 1 indexed citations
6.
Krishnamoorthy, Sriram, Dipti Gupta, Nancy Moore, et al.. (2016). VLA‐4 blockade by natalizumab inhibits sickle reticulocyte and leucocyte adhesion during simulated blood flow. British Journal of Haematology. 174(6). 970–982. 20 indexed citations
7.
Maserejian, Nancy N., et al.. (2015). Beta-Thalassemia Treatment and Complications in Two Large US Insured Population Databases. Blood. 126(23). 3278–3278. 3 indexed citations
8.
9.
Hines, Patrick C., Sriram Krishnamoorthy, Dipti Gupta, et al.. (2014). Natalizumab Blocks VLA-4 Mediated Red Blood Cell Adhesion and Is a Potential Therapy for Sickle Cell Disease. Blood. 124(21). 221–221. 2 indexed citations
10.
Hobbs, William E., et al.. (2013). Cocaine and Specific Cocaine Metabolites Induce von Willebrand Factor Release From Endothelial Cells in a Tissue-Specific Manner. Arteriosclerosis Thrombosis and Vascular Biology. 33(6). 1230–1237. 25 indexed citations
11.
Pagano, Monica B., William E. Hobbs, Michael Linenberger, & Meghan Delaney. (2012). Plasma and red cell exchange transfusions for erythropoietic protoporphyria: A case report and review of the literature. Journal of Clinical Apheresis. 27(6). 336–341. 22 indexed citations
12.
Chen, Junmei, William E. Hobbs, Jennie Le, et al.. (2011). The rate of hemolysis in sickle cell disease correlates with the quantity of active von Willebrand factor in the plasma. Blood. 117(13). 3680–3683. 71 indexed citations
13.
Hobbs, William E., et al.. (2011). Cocaine and Certain of Its Long-Acting Metabolites Stimulate Endothelial Cell Von Willebrand Factor Secretion. Blood. 118(21). 1148–1148. 1 indexed citations
14.
Hobbs, William E. & José A. López. (2008). Shear elegance: regulation of thrombus growth by shear stress. Blood. 111(3). 972–972.
15.
Lietman, Steven A., William E. Hobbs, Nozomu Inoue, & A. Hari Reddi. (2003). Effects of Selected Growth Factors on Porcine Meniscus in Chemically Defined Medium. Orthopedics. 26(8). 799–803. 34 indexed citations
16.
Hobbs, William E., et al.. (2002). Expression of Herpes Simplex Virus ICP0 Inhibits the Induction of Interferon-Stimulated Genes by Viral Infection. Journal of Virology. 76(5). 2180–2191. 150 indexed citations
17.
Casey, Patrick J., et al.. (1982). Radioisotope Dilution Technique for Determination of Vitamin B12 in Foods. Journal of AOAC INTERNATIONAL. 65(1). 85–88. 21 indexed citations
18.
Hobbs, William E., et al.. (1979). Comparative Study of Two Methods for Extraction of Aflatoxin from Peanut Meal and Peanut Butter. Journal of AOAC INTERNATIONAL. 62(6). 1281–1284. 4 indexed citations
19.
Taylor, K. Grant, et al.. (1972). Carbenoids with neighboring heteroatoms. III. Electrophilic reactions of two .alpha.-halocyclopropyllithium compounds. The Journal of Organic Chemistry. 37(15). 2436–2443. 34 indexed citations
20.
Taylor, K. Grant & William E. Hobbs. (1968). 7--bromo-2-oxabicyclo[4.1.0]hept-7-yl lithium. Tetrahedron Letters. 9(10). 1221–1223. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Jennifer Barks Breakdown of academic impact, for papers by Kurt C. Sizer Breakdown of academic impact, for papers by Lacramioara Ivanciu Breakdown of academic impact, for papers by Timothy A. Driscoll Breakdown of academic impact, for papers by Carsten Berges Breakdown of academic impact, for papers by Y. Matsuda Breakdown of academic impact, for papers by Cristian R. Smulski Breakdown of academic impact, for papers by Laphalle Fuller Breakdown of academic impact, for papers by Michael Plotnick Breakdown of academic impact, for papers by Drago Batinić
Rankless by CCL
2026